戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1            Subsequent oxidation provides the indolequinone.
2 patible with the predicted absorption of 5,6-indolequinone (1Q).
3 nd to be opposite to that observed for other indolequinones acting as substrates.
4 gn of both NQO1-inhibitory and noninhibitory indolequinone analogues allowed us to test the hypothesi
5 sisting of four monomer units (hydroquinone, indolequinone, and its two tautomers), in arrangements t
6                      We describe a series of indolequinones as efficient mechanism-based inhibitors o
7      In this report, we describe a series of indolequinones, based on 5-methoxy-1,2-dimethyl-3-[(4-ni
8                                  A series of indolequinones bearing various functional groups has bee
9 eatic tumor xenograft in nude mice, and lead indolequinones demonstrated high efficacy and low toxici
10  of the FAD in the active site of NQO2 by an indolequinone-derived iminium electrophile to the wider
11 nyltetrazolium (MTT) and clonogenic assays]; indolequinones displayed potent cytotoxicity against all
12                                          The indolequinone ES936 {5-methoxy-1,2-dimethyl-3-[(4-nitrop
13 growth inhibitory activity of this series of indolequinones in human pancreatic cancer.
14 nd may provide a biomarker of effect of lead indolequinones in this type of cancer.
15                                  A series of indolequinones including derivatives of EO9 bearing vari
16                                        These indolequinones induced caspase-dependent apoptosis but n
17                                              Indolequinones inhibited NQO2 activity in K562 cells at
18  iminium electrophile to the wider series of indolequinone inhibitors.
19                           The examination of indolequinone interactions in complex with NQO1 from com
20                                              Indolequinones (IQs) were developed as potential antitum
21 le indole derivatives to their corresponding indolequinones is described.
22 des the key step in a short synthesis of two indolequinone natural products.
23 specificity exists, but minor changes to the indolequinone nucleus have a significant effect upon sub
24             A series of 2- and 3-substituted indolequinone phosphoramidate prodrugs targeted to DT-di
25  Previously a series of 2- and 3-substituted indolequinone phosphoramidate prodrugs was synthesized,
26 ions demonstrated favorable conformations of indolequinones positioned directly above and in parallel
27 oles and subsequent oxidation to the desired indolequinones, thereby demonstrating a powerful applica
28                The ability of this series of indolequinones to inhibit recombinant human NQO1 correla
29       The unsaturated nature of C-C bonds in indolequinone units and the finite size of protomolecule
30                      In vivo efficacy of the indolequinones was also tested in the MIA PaCa-2 pancrea
31                  A potential target of these indolequinones was identified as thioredoxin reductase.
32  Inhibition of recombinant human NQO2 by the indolequinones was NRH-dependent, with kinetic parameter
33               The mechanism of action of the indolequinones was shown to involve metabolic reduction,
34 hree cell lines, and two specific classes of indolequinone were particularly potent agents.
35                                     Selected indolequinones were also screened against the NCI-60 cel
36                                              Indolequinones were found to be potent inhibitors of thi
37                                        These indolequinones were irreversible inhibitors and were fou
38                                          The indolequinones with 4-nitrophenoxy, 4-pyridinyloxy, and
39  The objective of this study was to identify indolequinones with improved potency against pancreatic

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。